Form 4: ACMR CFO Exercises Options, Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


ACM Research CFO Lisa Feng exercised stock options and subsequently sold shares of Class A Common Stock under a pre-arranged trading plan on November 12 and 13, 2025.

Summary

  • Lisa Feng, Chief Financial Officer of ACM Research (Shanghai), Inc., a subsidiary of ACM Research, Inc. (ACMR), reported transactions involving Class A Common Stock.
  • On November 12, 2025, Feng exercised stock options to acquire 15,000 shares of Class A Common Stock at an exercise price of $5.60 per share.
  • Immediately following the exercise on November 12, 2025, Feng sold 15,000 shares of Class A Common Stock at a price of $32.76 per share.
  • On November 13, 2025, Feng again exercised stock options to acquire 15,000 shares of Class A Common Stock at an exercise price of $5.60 per share.
  • Immediately following the exercise on November 13, 2025, Feng sold 15,000 shares of Class A Common Stock at a price of $33.77 per share.
  • All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted on August 13, 2025.
  • Following these transactions, Feng beneficially owns 50,001 shares of Class A Common Stock.
  • The stock options exercised were fully vested and exercisable with an expiration date of April 22, 2029.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions (option exercise and sale) executed under a pre-arranged 10b5-1 plan. While insider selling can sometimes be viewed cautiously, the planned nature of the transactions and the significant profit realized by the insider suggest a neutral impact on the company's fundamental outlook.

Positives

  • The reporting person realized a significant profit by exercising options at $5.60 and selling shares at average prices of $32.76 and $33.77.
  • The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating planned personal financial management rather than a reaction to new, non-public information.

Negatives

  • Insider selling, even under a 10b5-1 plan, can sometimes be viewed with caution by investors, as it reduces the insider's direct equity stake in the company.

Future Outlook

No forward-looking statements or guidance are provided in this insider transaction report.

Industry Context

This Form 4 filing reports routine insider transactions and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: May observe a reduction in direct insider ownership, though the planned nature of the sale mitigates concerns.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Key Dates

DateDescription
2025-08-13Date Rule 10b5-1 trading plan was adopted by the reporting person.
2025-11-12Reporting person exercised options to purchase 15,000 shares and sold 15,000 shares of Class A Common Stock.
2025-11-13Reporting person exercised options to purchase 15,000 shares and sold 15,000 shares of Class A Common Stock.
2025-11-14Date the Form 4 was signed by the attorney-in-fact.
2029-04-22Expiration date of the exercised stock options.

Keywords

ACMR, ACM Research, Lisa Feng, Insider Trading, Form 4, Stock Options, Beneficial Ownership, 10b5-1 Plan, Equity Sales, CFO

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.